Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Aventis Pharma Ltd., 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Or trading as Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Tritace 1.25 mg Tablets
or
Ramipril 1.25mg Tablets
| Pharmaceutical Form |
|---|
|
Tablets 1.25mg. White to almost white oblong tablet with dimensions of 8 × 4 mm with score-line. Upper stamp: 1.25 & logo ( Lower stamp: HMN & 1.25 The score-line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Tablets.
Each tablet contains ramipril 1.25 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ramipril |
Ramiprilat, the active metabolite of the prodrug ramipril, inhibits the enzyme dipeptidylcarboxypeptidase I (synonyms: angiotensin-converting enzyme; kininase II). In plasma and tissue this enzyme catalyses the conversion of angiotensin I to the active vasoconstrictor substance angiotensin II, as well as the breakdown of the active vasodilator bradykinin. Reduced angiotensin II formation and inhibition of bradykinin breakdown lead to vasodilatation. |
| List of Excipients |
|---|
|
Hypromellose |
Packs of 14, 15, 20, 28, 30, 50, 90, 98, 100 tablets in PVC/Alu blisters.
500 tablets in brown type III (Ph. Eur.) glass bottle with HDPE screw cap.
Not all pack sizes may be marketed.
Aventis Pharma Ltd., 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Or trading as
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0356
Date of first authorisation: 30th September 2003
Date of latest renewal: 31st March 2012
| Drug | Countries | |
|---|---|---|
| TRITACE | Austria, Australia, Hong Kong, Croatia, Ireland, Israel, Mexico, Nigeria, Poland, Romania, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
)